Literature DB >> 19522453

Unusual case of thiamine responsive megaloblastic anemia.

Faten Tinsa1, Saadia Ben Amor, Naziha Kaabachi, Mehdi Ben Lasouad, Khadija Boussetta, Souad Bousnina.   

Abstract

BACKGROUND: Thiamine-responsive megaloblastic anemia syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and neurosensoriel deafness, responding in varying degrees to thiamine treatment. AIM: Report an unusual case of this rare disorder CASE REPORT: We report the case of a four-year-old boy who presented unusual features of thiamine-responsive megaloblastic anemia. In addition to the typical triad of the syndrome, he presented leuconeutropenia, hepatosplenomegalia, cardiac abnormalities including absent P waves, mitral and tricuspid insufficiency, retinitis pigmentosa, nystagmus, developmental delay and a brain Magnetic resonance imaging ischemic lesion. Lactate levels in serum and the lactate/pyruvate ratio were increased. The mitochondrial mutation m.3243A > G located in MTTL1 gene encoding for transfer RNA leucine (tRNALeu(UUR)) was not found. Treatment with thiamine resulted in normalisation of the haemoglobin level, white cell count, and glucose and lactate levels. On three years follow up, the patient did not need insulinotherapy.
CONCLUSION: These data sign the crucial role that thiamine plays for many cells and tissues and its importance in the activity of the respiratory chain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522453

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  2 in total

1.  Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.

Authors:  Daniel B Larach; W Andrew Kofke; Peter Le Roux
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

2.  TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.

Authors:  Xin Li; Qing Cheng; Yu Ding; Qun Li; Ruen Yao; Jian Wang; Xiumin Wang
Journal:  BMC Pediatr       Date:  2019-07-11       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.